Movatterモバイル変換


[0]ホーム

URL:


Jump to content
WikipediaThe Free Encyclopedia
Search

2C2-NBOMe

From Wikipedia, the free encyclopedia
Chemical compound
Pharmaceutical compound
2C2-NBOMe
Clinical data
Other namesNBOMe-MMDPEA-2; MMDPEA-2-NBOMe; 2C-MMDA-2-NBOMe; 2C-2-NBOMe;N-(2-Methoxybenzyl)-2-methoxy-4,5-methylenedioxyphenethylamine
Drug classSerotonin5-HT2 receptoragonist;Serotonergic psychedelic;Hallucinogen
ATC code
  • None
Identifiers
  • N-(2-methoxybenzyl)-1-(2-methoxy-4,5-methylenedioxyphenyl)-2-aminoethane
Chemical and physical data
FormulaC18H21NO4
Molar mass315.369 g·mol−1
3D model (JSmol)
  • COc1ccccc1CNCCc1cc2OCOc2cc1OC
  • InChI=1S/C18H21NO4/c1-20-15-6-4-3-5-14(15)11-19-8-7-13-9-17-18(23-12-22-17)10-16(13)21-2/h3-6,9-10,19H,7-8,11-12H2,1-2H3
  • Key:XPZZCRFMAACBFQ-UHFFFAOYSA-N

2C2-NBOMe, also known as2C-MMDA-2-NBOMe orNBOMe-MMDPEA-2, is aphenethylaminederivative from the25-NB (NBOMe) family.[1][2] It is the NBOMederivative of2C-MMDA-2 (MMDPEA-2).[2]

It acts as apotentagonist at theserotonin5-HT2Areceptor with weaker activity at5-HT2B and5-HT2C, and produces ahead-twitch response in animal studies which often correlates with potential forpsychedelic effects in humans.[1][2]

It is related in structure to psychedelic phenethylamine derivatives such asMMDA-2 andlophophine (MMDPEA) and is the first phenethylamine derivative with amethylenedioxy substitution on the phenyl ring but no alkyl substitution on the alpha carbon, that has been shown to produce psychedelic-appropriate responding in animals.[1][2]

The drug was first described in the literature byJason Wallach and colleagues in 2022 and 2023.[1][2]

See also

[edit]

References

[edit]
  1. ^abcdWO 2022241006, Wallach J, McCorvy J, Halberstadt A, "Selective, Partial and Arrestin-Biased 5-HT2A Agonists with Utility in Various Disorders.", published 17 November 2022, assigned to Saint Joseph's University, The Medical College Of Wisconsin, Inc., The Regents Of The University Of California 
  2. ^abcdeWallach J, Cao AB, Calkins MM, Heim AJ, Lanham JK, Bonniwell EM, et al. (July 2023)."Identification of 5-HT2A Receptor Signaling Pathways Responsible for Psychedelic Potential".bioRxiv.doi:10.1101/2023.07.29.551106.PMC 10418054.PMID 37577474.

External links

[edit]
Tryptamines
No ring subs.
4-Hydroxytryptamines
5-Hydroxytryptamines
5-Methoxytryptamines
Other ring subs.
α-Alkyltryptamines
Others
Cyclized
Bioisosteres
Phenethylamines
Scalines
2C-x
3C-x
DOx
4C-x
Ψ-PEA
MDxx
FLY
25x-NB (NBOMes)
Others
Cyclized
Lysergamides
  • Bioisosteres:JRT
Others
Natural sources
5-HT1
5-HT1A
5-HT1B
5-HT1D
5-HT1E
5-HT1F
5-HT2
5-HT2A
5-HT2B
5-HT2C
5-HT37
5-HT3
5-HT4
5-HT5A
5-HT6
5-HT7
Phenethylamines
Amphetamines
Phentermines
Cathinones
Phenylisobutylamines
(and further-extended)
Catecholamines
(and close relatives)
Cyclized
phenethylamines
Phenylalkylpyrrolidines
2-Benzylpiperidines
(phenidates)
Phenylmorpholines
(phenmetrazines)
Phenyloxazolamines
(aminorexes)
Isoquinolines and
tetrahydroisoquinolines
2-Aminoindanes
2-Aminotetralins
Others / unsorted
Related compounds


Stub icon

Thishallucinogen-related article is astub. You can help Wikipedia byexpanding it.

Retrieved from "https://en.wikipedia.org/w/index.php?title=2C2-NBOMe&oldid=1322812797"
Categories:
Hidden categories:

[8]ページ先頭

©2009-2025 Movatter.jp